The Claim
A single-case analysis indicates that after one year of gender-affirming hormone therapy, a transgender female cyclist may experience a reduction in physiological advantages compared to cisgender female athletes, although performance metrics showed variability across different domains.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
One transgender woman cyclist on hormone therapy for a year might have lost some physical edge over cis women cyclists, but her performance changed in different ways depending on the type of test.
See the scientific wording
A single-case analysis suggests that after one year of gender-affirming hormone therapy, a transgender female cyclist may have reduced physiological advantages relative to cisgender female athletes, though performance metrics remained variable across domains.
What the research says
1 studyThe study looked at a transgender woman cyclist on hormone therapy and found that after a year, her strength and endurance decreased, making her more similar to cisgender female cyclists, though some differences remained.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.